Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haolun Ding

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Computational Intelligence and Neuroscience|December 5, 2022
Integrated Development of Artificial Intelligence and Economic ManagementYixing He, Haolun Ding
JCO Precision Oncology|July 8, 2024
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNAHaolun Ding, Xu Steven Xu, Yaning Yang, et al.
NPJ Precision Oncology|January 8, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications|August 10, 2024
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Computers in Biology and Medicine|March 5, 2025
Discovery of mutations predictive of survival benefit from immunotherapy in first-line NSCLC: A retrospective machine learning study of IMpower150 liquid biopsy dataMin Yuan, Wei Feng, Haolun Ding, et al.
JTO Clinical and Research Reports|November 24, 2025
Evaluating Circulating Tumor DNA Clearance as an Early Intermediate End Point Predicting Clinical Benefit in Metastatic Nonsquamous NSCLC After First-Line ChemoimmunotherapyMin Yuan, Haolun Ding, Weiwei Zhuang, et al.
Clinical Pharmacology and Therapeutics|September 19, 2023
Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in Colorectal Cancer Using Modeling and Machine LearningHaolun Ding, Min Yuan, Yaning Yang, et al.
Neural Networks : the Official Journal of the International Neural Network Society|November 7, 2025
Probabilistic Bayesian learning with long-tail awareness for trajectory-user linkingHaolun Ding, Zhengwen Fu, Rong Zhang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 17, 2025
Treatment-agnostic joint modeling of longitudinal circulating tumor dna predicts survival across first-line regimens in metastatic non-squamous NSCLCMin Yuan, Xin Lin, Haolun Ding, et al.
JCO Clinical Cancer Informatics|January 17, 2024
Image-Based Subtype Classification for Glioblastoma Using Deep Learning: Prognostic Significance and Biologic RelevanceMin Yuan, Haolun Ding, Bangwei Guo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Computational Intelligence and Neuroscience|December 5, 2022
Integrated Development of Artificial Intelligence and Economic ManagementYixing He, Haolun Ding
JCO Precision Oncology|July 8, 2024
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNAHaolun Ding, Xu Steven Xu, Yaning Yang, et al.
NPJ Precision Oncology|January 8, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications|August 10, 2024
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Computers in Biology and Medicine|March 5, 2025
Discovery of mutations predictive of survival benefit from immunotherapy in first-line NSCLC: A retrospective machine learning study of IMpower150 liquid biopsy dataMin Yuan, Wei Feng, Haolun Ding, et al.
JTO Clinical and Research Reports|November 24, 2025
Evaluating Circulating Tumor DNA Clearance as an Early Intermediate End Point Predicting Clinical Benefit in Metastatic Nonsquamous NSCLC After First-Line ChemoimmunotherapyMin Yuan, Haolun Ding, Weiwei Zhuang, et al.
Clinical Pharmacology and Therapeutics|September 19, 2023
Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in Colorectal Cancer Using Modeling and Machine LearningHaolun Ding, Min Yuan, Yaning Yang, et al.
Neural Networks : the Official Journal of the International Neural Network Society|November 7, 2025
Probabilistic Bayesian learning with long-tail awareness for trajectory-user linkingHaolun Ding, Zhengwen Fu, Rong Zhang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 17, 2025
Treatment-agnostic joint modeling of longitudinal circulating tumor dna predicts survival across first-line regimens in metastatic non-squamous NSCLCMin Yuan, Xin Lin, Haolun Ding, et al.
JCO Clinical Cancer Informatics|January 17, 2024
Image-Based Subtype Classification for Glioblastoma Using Deep Learning: Prognostic Significance and Biologic RelevanceMin Yuan, Haolun Ding, Bangwei Guo, et al.
Pageof 2